Time: 9:30 am, May 25(Wednesday)
Location: Biology building hall
David A. Weitz
Abstract：This talk will describe the microfluidic technology that enables the use of droplets whose volume is picoliters in assays that have potential to impact precision medicine and bring new diagnostic and therapeutic applications to the clinic. These droplet-based microfluidic techniques enable many different applications including very sensitive detection of minute amounts of reagents through PCR amplification methods, or single cell analysis techniques through genomic barcoding and readout through sequencing methods. Several different applications will be described.
Mallinckrodt Professor of Physics and Applied Physics at Harvard University
Member of the National Academy of Sciences
Member of the National Academy of Engineering
Member of the American Academy of Arts and Sciences
Director of the Materials Research Science and Engineering Center
Co-Director of the BASF Advanced Research Initiative
Introduction
Prof. David A. Weitz is the Mallinckrodt Professor of Physics and Applied Physics and professor of Systems Biology at Harvard University. He is the Director of Harvard's NSF-funded Materials Research Science and Engineering Center, and the co-Director of the BASF Advanced Research Initiative as well as a member of the Kavli Institute of Bionano Science and Technology.
His research efforts include soft matter physics, colloidal physics, biological materials, drop-based microfluidics for biophysics and biotechnology applications, droplet control, single cells analysis and rapid biological molecular detection, drug controlled release new material development and translational medicine research.
Prof. David A. Weitz had published more than 500 peer-reviewed papers, some of them were published on top international journals like Science、Nature、Cell and Nature Biotechnology, etc. Until now, his papers were referred more than 58000 times, and he had a Hirsch index of 129. He had filed more than 60 patents to date, and founded twelve hi-tech companies.